Director, Center for Biologics Evaluation and Research
United States Food and Drug Administration
Dr. Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016. He is a Fellow of the American College of Physicians and a member of the National Academy of Medicine.
Thursday, September 19, 2024
9:15 AM – 10:30 AM PDT
Health Authority Forum: CBER - FDA’s Center for Biologics Evaluation and Research (CBER)
Thursday, September 19, 2024
3:15 PM – 4:15 PM PDT